| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0378-5955(98)00200-7 |
| P698 | PubMed publication ID | 10082291 |
| P2093 | author name string | J Schacht | |
| S H Sha | |||
| P2860 | cites work | A method for removal of trace iron contamination from biological buffers | Q68991186 |
| Lucigenin chemiluminescence in the assessment of neutrophil superoxide production | Q70166605 | ||
| Direct detection of ototoxicant-induced reactive oxygen species generation in cochlear explants | Q71703824 | ||
| Lucigenin (bis-N-methylacridinium) as a mediator of superoxide anion production | Q71960880 | ||
| Renal cortical mitochondria are the source of oxygen free radicals enhanced by gentamicin | Q72287127 | ||
| Oxygen free radicals are not the main factor in experimental gentamicin nephrotoxicity | Q72749107 | ||
| Evidence suggesting a role for hydroxyl radical in gentamicin-induced acute renal failure in rats | Q28360981 | ||
| Kinetics of gentamicin uptake and release in the rat. Comparison of inner ear tissues and fluids with other organs | Q30501061 | ||
| Evidence for role of hydroxyl radical in complement and neutrophil-dependent tissue injury | Q33822202 | ||
| Comparative uptake of gentamicin, netilmicin, and amikacin in the guinea pig cochlea and vestibule | Q35574233 | ||
| Polymorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease | Q39496586 | ||
| Isolation of an aminoglycoside receptor from guinea pig inner ear tissues and kidney | Q40257083 | ||
| Validation of lucigenin (bis-N-methylacridinium) as a chemilumigenic probe for detecting superoxide anion radical production by enzymatic and cellular systems | Q41069909 | ||
| Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat. | Q41384445 | ||
| Superoxide production by normal and chronic granulomatous disease (CGD) patient-derived EBV-transformed B cell lines measured by chemiluminescence-based assays | Q41594655 | ||
| Biochemical characterization of a pedigree with mitochondrially inherited deafness | Q41595334 | ||
| Reactive oxygen species in chick hair cells after gentamicin exposure in vitro | Q45104194 | ||
| Variable efficacy of radical scavengers and iron chelators to attenuate gentamicin ototoxicity in guinea pig in vivo | Q46153611 | ||
| Characterization of aminoglycoside-lipid interactions and development of a refined model for ototoxicity testing | Q46244095 | ||
| Ototoxicity of aminoglycosides correlated with their action on monomolecular films of polyphosphoinositides | Q46405028 | ||
| Formation of a cytotoxic metabolite from gentamicin by liver | Q46799682 | ||
| Iron chelators protect from aminoglycoside-induced cochleo- and vestibulo-toxicity | Q47831985 | ||
| Attenuation of gentamicin ototoxicity by glutathione in the guinea pig in vivo | Q48105790 | ||
| Attenuation of neomycin ototoxicity by iron chelation. | Q50506670 | ||
| Formation of free radicals by gentamicin and iron and evidence for an iron/gentamicin complex. | Q50517643 | ||
| Sulfhydryl compounds and antioxidants inhibit cytotoxicity to outer hair cells of a gentamicin metabolite in vitro. | Q50524541 | ||
| Formation of a toxic metabolite from gentamicin by a hepatic cytosolic fraction. | Q50538811 | ||
| Effects of N-acetylcysteine on kanamycin ototoxicity in the guinea pig. | Q50593071 | ||
| Prophylaxis of kanamycin-induced ototoxicity by a radioprotectant | Q50602120 | ||
| Gentamicin enhanced production of hydrogen peroxide by renal cortical mitochondria. | Q53836950 | ||
| Chemiluminescence detection of H2O2 produced by human neutrophils during the respiratory burst | Q68529317 | ||
| P433 | issue | 1-2 | |
| P921 | main subject | antibiotic | Q12187 |
| P304 | page(s) | 112-118 | |
| P577 | publication date | 1999-02-01 | |
| P1433 | published in | Hearing Research | Q3040317 |
| P1476 | title | Stimulation of free radical formation by aminoglycoside antibiotics | |
| P478 | volume | 128 |
| Q36726249 | A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides |
| Q30388543 | ACEMg Diet Supplement Modifies Progression of Hereditary Deafness |
| Q37036270 | Activation of PI3K signaling prevents aminoglycoside-induced hair cell death in the murine cochlea |
| Q37068636 | Advances in molecular and cellular therapies for hearing loss. |
| Q92958757 | Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment |
| Q44066693 | Amikacin ototoxicity enhanced by Ginkgo biloba extract (EGb 761). |
| Q22306318 | Aminoglycoside Prescribing and Surveillance in Cystic Fibrosis |
| Q43708426 | Aminoglycoside ototoxicity in adult CBA, C57BL and BALB mice and the Sprague-Dawley rat. |
| Q73054034 | Aminoglycosides activate oxygen metabolites production in the cochlea of mature and developing rats |
| Q36496018 | An expanding view of aminoglycoside-nucleic acid recognition |
| Q38623189 | An overview of pharmacology and clinical aspects concerning the therapy of cochleo-vestibular syndromes by intratympanic drug delivery |
| Q48130264 | Antibiotic Treatment Preventing Necrotising Enterocolitis Alters Urinary and Plasma Metabolomes in Preterm Pigs |
| Q38322234 | Antimicrobial peptides and endotoxin inhibit cytokine and nitric oxide release but amplify respiratory burst response in human and murine macrophages |
| Q43169212 | Antioxidant gene therapy can protect hearing and hair cells from ototoxicity |
| Q50496958 | Antioxidants attenuate gentamicin-induced free radical formation in vitro and ototoxicity in vivo: D-methionine is a potential protectant. |
| Q30410332 | Assessment of nutrient supplement to reduce gentamicin-induced ototoxicity |
| Q46254676 | Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death |
| Q74293270 | Blockade of c-Jun N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death |
| Q36003761 | Borrelia burgdorferi, a pathogen that lacks iron, encodes manganese-dependent superoxide dismutase essential for resistance to streptonigrin |
| Q44156181 | Caspase activation in hair cells of the mouse utricle exposed to neomycin. |
| Q42527878 | Chinchilla models of selective cochlear hair cell loss |
| Q33882620 | Clinical pharmacokinetics and pharmacodynamics of isepamicin |
| Q30619790 | Designer aminoglycosides prevent cochlear hair cell loss and hearing loss |
| Q42407358 | Disruption of gap junctions attenuates aminoglycoside-elicited renal tubular cell injury |
| Q27681169 | Dissociation of antibacterial activity and aminoglycoside ototoxicity in the 4-monosubstituted 2-deoxystreptamine apramycin |
| Q30240026 | Drug-induced ototoxicity: Mechanisms, Pharmacogenetics, and protective strategies |
| Q41841911 | Effect of Taurine on the antimicrobial efficiency of Gentamicin. |
| Q30497092 | Effects of antioxidants on auditory nerve function and survival in deafened guinea pigs |
| Q46381211 | Effects of co-supplementation of vitamins E and C on gentamicin-induced nephrotoxicity in rat. |
| Q46252831 | Effects of peroxisome proliferator activated receptors (PPAR)-γ and -α agonists on cochlear protection from oxidative stress |
| Q46127931 | Efficacy of the combination of N-acetylcysteine and desferrioxamine in the prevention and treatment of gentamicin-induced acute renal failure in male Wistar rats |
| Q42457472 | Experimental morphological and functional study of gentamicin cochleotoxicity using the regular dose given to neonates |
| Q37714144 | Fenofibrate exerts protective effects against gentamicin-induced toxicity in cochlear hair cells by activating antioxidant enzymes |
| Q37315332 | Generation of highly-reactive oxygen species is closely related to hair cell damage in rat organ of Corti treated with gentamicin |
| Q46805525 | Gentamicin attenuates gentamicin-induced ototoxicity - self-protection |
| Q30489737 | Glial cell line-derived neurotrophic factor and antioxidants preserve the electrical responsiveness of the spiral ganglion neurons after experimentally induced deafness |
| Q40650824 | Hearing and hair cells are protected by adenoviral gene therapy with TGF-β1 and GDNF |
| Q34224262 | In vitro and in vivo models of drug ototoxicity: studying the mechanisms of a clinical problem |
| Q55407610 | Increased risk of aminoglycoside-induced hearing loss in MDR-TB patients with HIV coinfection. |
| Q30837170 | Involvement of the mitochondrial permeability transition in gentamicin ototoxicity |
| Q30489783 | JNK signaling in neomycin-induced vestibular hair cell death |
| Q30317246 | Local drug therapy for inner ear hearing loss |
| Q50484778 | M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. |
| Q28393038 | Mechanisms of aminoglycoside ototoxicity and targets of hair cell protection |
| Q44050754 | Melanin potentiates gentamicin-induced inhibition of collagen biosynthesis in human skin fibroblasts. |
| Q38353200 | Molecular basis of hair cell loss |
| Q43652750 | Nitric oxide in guinea pig vestibular sensory cells following gentamicin exposure in vitro |
| Q46813061 | Nitro-L-arginine methyl ester: a potential protector against gentamicin ototoxicity |
| Q41526695 | Non-autonomous Cellular Responses to Ototoxic Drug-Induced Stress and Death |
| Q33982886 | Occurrence and risk of cochleotoxicity in cystic fibrosis patients receiving repeated high-dose aminoglycoside therapy. |
| Q36281577 | Ototoxicity: therapeutic opportunities |
| Q44164025 | Oxidative stress induced by ciprofloxacin in Staphylococcus aureus |
| Q46943010 | Pomegranate extract: a potential protector against aminoglycoside ototoxicity |
| Q43823565 | Potentiation of noise-induced hearing loss by amikacin in guinea pigs |
| Q34588145 | Profiling drug-induced cell death pathways in the zebrafish lateral line |
| Q40007967 | Protection Against Aminoglycoside-induced Ototoxicity by Regulated AAV Vector-mediated GDNF Gene Transfer Into the Cochlea |
| Q42439954 | Protective Effects of α-Tocopherol Against Gentamicin-induced Oto-vestibulo Toxicity: An Experimental Study |
| Q31160169 | Protective role of edaravone against neomycin-induced ototoxicity in zebrafish. |
| Q42467486 | Self-protection against aminoglycoside ototoxicity in guinea pigs |
| Q30532001 | Tanshinone (Salviae miltiorrhizae extract) preparations attenuate aminoglycoside-induced free radical formation in vitro and ototoxicity in vivo |
| Q50458607 | The role of deferoxamine in the prevention of gentamicin ototoxicity: a histological and audiological study in guinea pigs |
| Q26853614 | Therapeutic suppression of premature termination codons: mechanisms and clinical considerations (review) |
| Q50458358 | Ultrastructural analysis of aminoglycoside-induced hair cell death in the zebrafish lateral line reveals an early mitochondrial response |
| Q36446895 | Understanding drug ototoxicity: molecular insights for prevention and clinical management |
| Q38841951 | Uptake of gentamicin by bullfrog saccular hair cells in vitro |
| Q36446781 | d-Methionine reduces tobramycin-induced ototoxicity without antimicrobial interference in animal models |
Search more.